Home > Insider Trading > Filing (0000899243-19-021636)

Filing Details

Accession Number:: 0000899243-19-021636
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-13 16:05:41
Reporting Period:: 2019-08-12

Accepted Time:: 2019-08-13 16:05:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1666071	Cardlytics Inc.	CDLX	()	E9

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1419148	Canaan Viii Lp	C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880		Yes	No	No	No
1552200	Canaan Partners Viii Llc	C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-08-12	84,185	$31.80	103,498	No	4	S	Direct
Common Stock	Disposition	2019-08-12	2,600	$33.11	100,898	No	4	S	Direct
Common Stock	Disposition	2019-08-12	100,898	$32.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.75 - $32.185, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held directly by Canaan VIII L.P. (the "Canaan Fund"). Canaan Partners VIII LLC ("Canaan VIII") is the sole general partner of the Canaan Fund, and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. John Balen is a manager and member of Canaan VIII. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan VIII, collectively. Canaan VIII disclaims Section 16 beneficial ownership of the shares held by the Canaan Fund, except to the extent, if any, of its pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 - $33.21, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.75 - $32.50, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.